Literature DB >> 10772651

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.

I A Leclercq1, G C Farrell, J Field, D R Bell, F J Gonzalez, G R Robertson.   

Abstract

Nonalcoholic steatohepatitis (NASH) and alcoholic liver disease have similar pathological features. Because CYP2E1 plays a key role in alcoholic liver disease with its ability to stimulate lipid peroxidation, we tested the proposal that CYP2E1 could also be a factor in the development of NASH. In a dietary model - mice fed a methionine- and choline-deficient (MCD) diet - liver injury was associated with both induction of CYP2E1 and a 100-fold increase in hepatic content of lipid peroxides. Microsomal NADPH-dependent lipid oxidases contributed to the formation of these lipid peroxides, and in vitro inhibition studies demonstrated that CYP2E1 was the major catalyst. To further define the role of CYP2E1 as an initiator of oxidative stress in NASH, Cyp2e1(-/-)mice were administered the MCD diet. CYP2E1 deficiency neither prevented the development of NASH nor abrogated the increased microsomal NADPH-dependent lipid peroxidation, indicating the operation of a non-CYP2E1 peroxidase pathway. In Cyp2e1(-/-) mice with NASH (but not in wild-type mice), CYP4A10 and CYP4A14 were upregulated. Furthermore, hepatic microsomal lipid peroxidation was substantially inhibited by anti-mouse CYP4A10 antibody in vitro. These results show that experimental NASH is strongly associated with hepatic microsomal lipid peroxidation. CYP2E1, the main enzyme associated with that process in wild-type mice, is not unique among P450 proteins in catalyzing peroxidation of endogenous lipids. We have now identified CYP4A enzymes as alternative initiators of oxidative stress in the liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772651      PMCID: PMC300833          DOI: 10.1172/JCI8814

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

Authors:  H Ohkawa; N Ohishi; K Yagi
Journal:  Anal Biochem       Date:  1979-06       Impact factor: 3.365

2.  Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects.

Authors:  F P Guengerich; D H Kim; M Iwasaki
Journal:  Chem Res Toxicol       Date:  1991 Mar-Apr       Impact factor: 3.739

3.  CYP2E1 is not involved in early alcohol-induced liver injury.

Authors:  H Kono; B U Bradford; M Yin; K K Sulik; D R Koop; J M Peters; F J Gonzalez; T McDonald; A Dikalova; M B Kadiiska; R P Mason; R G Thurman
Journal:  Am J Physiol       Date:  1999-12

4.  Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetes.

Authors:  C R Barnett; G G Gibson; C R Wolf; P R Flatt; C Ioannides
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

5.  Possible role of aldehydic lipid peroxidation products as chemoattractants.

Authors:  M Curzio; H Esterbauer; G Poli; F Biasi; G Cecchini; C Di Mauro; N Cappello; M U Dianzani
Journal:  Int J Tissue React       Date:  1987

6.  Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450.

Authors:  M Ingelman-Sundberg; I Johansson
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

7.  On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P-450. Products of oxygen reduction.

Authors:  L D Gorsky; D R Koop; M J Coon
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

8.  Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.

Authors:  A M Diehl; Z Goodman; K G Ishak
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

9.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

10.  Drug metabolism in cirrhosis. Selective changes in cytochrome P-450 isozymes in the choline-deficient rat model.

Authors:  M Murray; L Zaluzny; G C Farrell
Journal:  Biochem Pharmacol       Date:  1986-06-01       Impact factor: 5.858

View more
  186 in total

1.  Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet.

Authors:  Michael K Pickens; Hisanobu Ogata; Russell K Soon; James P Grenert; Jacquelyn J Maher
Journal:  Liver Int       Date:  2010-06-08       Impact factor: 5.828

2.  The role of ethanol metabolism in development of alcoholic steatohepatitis in the rat.

Authors:  Martin J Ronis; Soheila Korourian; Michael L Blackburn; Jamie Badeaux; Thomas M Badger
Journal:  Alcohol       Date:  2010-01-29       Impact factor: 2.405

3.  Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation.

Authors:  Rajat Singh; Yongjun Wang; Jörn M Schattenberg; Youqing Xiang; Mark J Czaja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

Review 4.  Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame.

Authors:  Samar H Ibrahim; Petra Hirsova; Harmeet Malhi; Gregory J Gores
Journal:  Dig Dis Sci       Date:  2015-12-01       Impact factor: 3.199

5.  Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats.

Authors:  Rachel J Perry; Dongyan Zhang; Xian-Man Zhang; James L Boyer; Gerald I Shulman
Journal:  Science       Date:  2015-02-26       Impact factor: 47.728

Review 6.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

7.  N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis.

Authors:  Duangporn Thong-Ngam; Suchittra Samuhasaneeto; Onanong Kulaputana; Naruemon Klaikeaw
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

8.  Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis.

Authors:  Michael K Pickens; Jim S Yan; Raymond K Ng; Hisanobu Ogata; James P Grenert; Carine Beysen; Scott M Turner; Jacquelyn J Maher
Journal:  J Lipid Res       Date:  2009-03-17       Impact factor: 5.922

9.  Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.

Authors:  Zaiqi Wang; Stephen D Hall; Juan F Maya; Lang Li; Ali Asghar; J C Gorski
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

10.  Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis.

Authors:  Jaideep Behari; Tzu-Hsuan Yeh; Lindsay Krauland; Wade Otruba; Benjamin Cieply; Beth Hauth; Udayan Apte; Tong Wu; Rhobert Evans; Satdarshan P S Monga
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.